Hangzhou MDK Opto Electronics Co., Ltd (688079.SH) forecasts a pre-loss, with an estimated net loss of approximately 98,927,000 yuan in 2024.
Medikai (688079.SH) announced that the company expects to achieve attributable net profit to the owner of the parent company in the annual 2024.
Hangzhou MDK Opto Electronics Co., Ltd. (688079.SH) announced that the company expects to incur a net loss of approximately 98.927 million yuan attributable to the owners of the parent company in the 2024 fiscal year.
Related Articles
ONEROBOTICS (06600): Further purchase of H shares and cornerstone investors have confidence in the long-term development of the group based on the H-share incentive plan for 2026.
CDB LEASING (01606) plans to purchase information technology computer equipment for operating leasing business.
Zhejiang Conba Pharmaceutical's subsidiary, Ketoconazole Slow-release Tablets, has obtained a drug registration certificate.
ONEROBOTICS (06600): Further purchase of H shares and cornerstone investors have confidence in the long-term development of the group based on the H-share incentive plan for 2026.
CDB LEASING (01606) plans to purchase information technology computer equipment for operating leasing business.
Zhejiang Conba Pharmaceutical's subsidiary, Ketoconazole Slow-release Tablets, has obtained a drug registration certificate.
RECOMMEND
